Category: Health & Medicines > Health Care Supplement > Sodium Glycerophosphate
Country/Region: China State/Province: Zhejiang
Main Products: Mirtazapine
Business Type: Manufacturer, Trader
Year Established: 2008
Employees: 11 - 50 People
Plant Area: 30,000-50,000 square meters
Main Markets: South America 8% Africa 11% Eastern Asia 12% Domestic Market 12% North America 8% Eastern Europe 8% Southern Europe 9% Mid East 9% Northern Europe 10% Oceania 13%
Trade Capacity: FOB, FCA, DES
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: Ningbo
Annual Revenue: US$5 Million - US$10 Million
Total Revenue: US$5 Million - US$10 Million
Export Revenue: Below US$1 Million
Annual Output: US$1 Million - US$2.5 Million
Registered Capital: Above US$100 Million
Export Percentage: 41% - 50%
Payment Modes: USD, JPY, GBP
Lead Time: 13 days
Import/Export Mode: LLC (Limited Liability Corp)